Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
20,501
-3,768
-16% -$199K 0.18% 78
2026
Q1
$1.34M Hold
24,269
0.25% 67
2025
Q4
$1.19M Sell
24,269
-374
-2% -$17.4K 0.22% 73
2025
Q3
$1.06M Sell
24,643
-2,942
-11% -$115K 0.2% 74
2025
Q2
$1.06M Buy
+27,585
New +$1.05M 0.21% 75

Other funds holding GSK

VeraBank's GSK Position: Q2 2026 in Review

VeraBank reduced its GSK (GSK) stake by 16% in Q2 2026, selling an estimated $199K and leaving 20,501 shares worth $1.07M. The position accounts for 0.18% of the portfolio, ranked #78.

VeraBank first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.34M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • VeraBank held 20,501 shares of GSK worth $1.07M as of Q2 2026.
  • VeraBank sold 3,768 GSK shares in Q2 2026, an estimated $199K.
  • GSK made up 0.18% of VeraBank's portfolio in Q2 2026, its #78 holding.
  • VeraBank first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • VeraBank's GSK position peaked at $1.34M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on VeraBank's 13F filing for Q2 2026, filed 6 Aug 2026.